BainbridgeJ.W., SmithA.J., BarkerS.S.et al.2008. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med., 358:2231–2239.
2.
MaguireA.M., SimonelliF., PierceE.A., PughE.N.Jr., MingozziF., BennicelliJ., BanfiS., MarshallK.A., TestaF., SuraceE.M., RossiS., LyubarskyA., ArrudaV.R., KonkleB., StoneE., SunJ., JacobsJ., Dell'OssoL., HertleR., MaJ.X., RedmondT.M., ZhuX., HauckB., ZelenaiaO., ShindlerK.S., MaguireM.G., WrightJ.F., VolpeN.J., McDonnellJ.W., AuricchioA., HighK.A., BennettJ.2008. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med., 358:2240–2248.
3.
HauswirthW.W., AlemanT.S., KaushalS., CideciyanA.V., SchwartzS.B., WangL., ConlonT.J., BoyeS.L., FlotteT.R., ByrneB.J., JacobsonS.G.2008. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum. Gene Ther., 19:979–990.
4.
CideciyanA.V., HauswirthW.W., AlemanT.S., KaushalS., SchwartzS.B., BoyeS.L., WindsorE.A., ConlonT.J., SumarokaA., RomanA.J., ByrneB.J., JacobsonS.G.2009. Vision 1 year after gene therapy for Leber's congenital amaurosis. N. Engl. J. Med., 361:725–727.
